≡ FDA Approves New SPRYCELÃ (Dasatinib) Product Labeling For Patients With Chronic-Phase CML Part 4
At the trend of analysis, 39 of 49 patients delivery Gleevec hold fractious done to SPRYCEL; 15 of 101 patients receiving SPRYCEL had crossed over to Gleevec. Crossover to alternate psychiatric therapy be permitted contained via the scheduled of virus improvement or insupportable toxicity. Median duration of usage prior to crossover was 14 […]
